Annual Total Long Term Liabilities
$0.00
$0.000.00%
December 31, 2023
Summary
- As of March 6, 2025, XTLB annual total long term liabilities is $0.00, unchanged on December 31, 2023.
- During the last 3 years, XTLB annual total long term liabilities has fallen by -$2.64 million (-100.00%).
- XTLB annual total long term liabilities is now -100.00% below its all-time high of $2.67 million, reached on December 31, 2017.
Performance
XTLB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.10 M
+$1.10 M+100.00%
September 30, 2024
Summary
- As of March 6, 2025, XTLB quarterly total long term liabilities is $1.10 million, with the most recent change of +$1.10 million (+100.00%) on September 30, 2024.
- Over the past year, XTLB quarterly long term liabilities has stayed the same.
- XTLB quarterly long term liabilities is now -76.68% below its all-time high of $4.70 million, reached on June 30, 2017.
Performance
XTLB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
XTLB Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | -100.0% | 0.0% |
| 5 y5 years | -100.0% | 0.0% |
XTLB Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | at high | -100.0% |
| 5 y | 5-year | -100.0% | at low | -69.5% | -100.0% |
| alltime | all time | -100.0% | at low | -76.7% | -100.0% |
XTL Biopharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.10 M(>+9900.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(-100.0%) |
| Jun 2022 | - | $22.00 K(-95.7%) |
| Mar 2022 | - | $517.00 K(-50.9%) |
| Dec 2021 | $1.05 M(-60.0%) | $1.05 M(-70.6%) |
| Sep 2021 | - | $3.59 M(+5.2%) |
| Jun 2021 | - | $3.41 M(+26.7%) |
| Mar 2021 | - | $2.69 M(+2.1%) |
| Dec 2020 | $2.64 M(+467.1%) | $2.64 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $465.00 K(-55.7%) | $465.00 K(>+9900.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(-100.0%) |
| Dec 2018 | $1.05 M(-60.7%) | $1.05 M(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $2.67 M(>+9900.0%) | $2.67 M(-8.6%) |
| Sep 2017 | - | $2.92 M(-37.9%) |
| Jun 2017 | - | $4.70 M(+25.3%) |
| Mar 2017 | - | $3.75 M(>+9900.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00 | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2014 | - | $27.00 K(0.0%) |
| Jun 2014 | - | $27.00 K(+170.0%) |
| Mar 2014 | - | $10.00 K(-9.1%) |
| Dec 2013 | $11.00 K(-15.4%) | $11.00 K(-15.4%) |
| Sep 2013 | - | $13.00 K(0.0%) |
| Jun 2013 | - | $13.00 K(0.0%) |
| Mar 2013 | - | $13.00 K(0.0%) |
| Dec 2012 | $13.00 K(>+9900.0%) | $13.00 K(>+9900.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2008 | - | $155.00 K(-20.1%) |
| Dec 2007 | $194.00 K(-73.7%) | $194.00 K(-49.7%) |
| Jun 2007 | - | $386.00 K(-47.7%) |
| Dec 2006 | $738.00 K(-50.6%) | $738.00 K(-29.2%) |
| Jun 2006 | - | $1.04 M(-30.2%) |
| Dec 2005 | $1.49 M(-40.0%) | $1.49 M(-14.7%) |
| Jun 2005 | - | $1.75 M(-29.7%) |
| Dec 2004 | $2.49 M(+100.1%) | $2.49 M(+33.4%) |
| Jun 2004 | - | $1.87 M |
| Dec 2003 | $1.24 M | - |
FAQ
- What is XTL Biopharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual total long term liabilities year-on-year change?
- What is XTL Biopharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly long term liabilities year-on-year change?
What is XTL Biopharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of XTLB is $0.00
What is the all time high annual total long term liabilities for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual total long term liabilities is $2.67 M
What is XTL Biopharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, XTLB annual total long term liabilities has changed by $0.00 (0.00%)
What is XTL Biopharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of XTLB is $1.10 M
What is the all time high quarterly long term liabilities for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly total long term liabilities is $4.70 M
What is XTL Biopharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, XTLB quarterly total long term liabilities has changed by $0.00 (0.00%)